Fortress Biotech, Inc. (FBIOP) vs KORU Medical Systems, Inc. (KRMD)

A side-by-side comparison of Fortress Biotech, Inc. and KORU Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIOP vs KRMD

growth of $100 · dividends reinvested · last 9y
FBIOP +66.3% (+5.8%/yr)KRMD +356.1% (+18.4%/yr)KRMD compounded faster over this window
05001k2kStart $1002019202120232025$166$456
FBIOP KRMD

FBIOP vs KRMD: by the numbers

  • •FBIOP is the larger company ($140M vs $137M market cap).
  • •FBIOP is profitable (163.32% net margin) while KRMD runs a net loss (-4.03%).
  • •KRMD grew revenue faster over the past five years (16.42% vs 5.39% CAGR).

Metrics side by side

Valuation

MetricFBIOPKRMD
P/E ratio6.62N/A
Forward P/E6.96N/A
P/S ratio2.043.04
P/B ratio0.857.58
FCF yield90.06%0.19%

Profitability

MetricFBIOPKRMD
Gross margin62.53%61.99%
Operating margin-111.00%-3.66%
Net margin163.32%-4.03%
ROE68.12%-10.08%
ROIC-10.85%-7.95%

Growth (annualized)

MetricFBIOPKRMD
Revenue CAGR (5Y)5.39%16.42%
Total return CAGR (5Y)0.05%1.60%

Frequently asked

Which has grown faster, FBIOP or KRMD?
Over the past five years, KRMD grew revenue faster — FBIOP at a 5.39% CAGR versus KRMD at 16.42%.
Is FBIOP or KRMD more profitable?
FBIOP runs the higher net margin — FBIOP at 163.32% versus KRMD at -4.03%.
How have FBIOP and KRMD total returns compared?
Over the past 5 years, FBIOP delivered 0.05% and KRMD delivered 1.60% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.